Want to join the conversation?
For 2Q17, $GES forecast EPS to be in the range of $0.11 to $0.16. Consolidated net revenues are expected to increase between 5.0% and 8.0%. For fiscal 2017, the company forecast GAAP diluted EPS in the range of $0.79 to $0.92. Consolidated net revenues are expected to increase between 3.0% and 5.0% in U.S. dollars in fiscal 2017.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?